CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform on Monday, June 17th. As previously communicated, the Grifols assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Panther Testing Platform. The new package insert, assay history list, and platform history list are now available on our website.
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...